Meanwhile, NICE also published new guidance supporting NHS use of an AI-based automated tool, ArtiQ's ArtiQ.Spiro, which ...

SaveHealth reports on 10 hypertension medications, their classifications, effectiveness, side effects, and safety in managing ...

People living with asthma could gain better access to digital tools to help them better manage their condition ...

The eight recommended digital technologies are: Asthmahub, Asthmahub for parents, AsthmaTuner, Digital Health Passport, Luscii, myAsthma, RDMP (Respiratory Disease Management Platform) and Smart ...

Six key groups must exercise caution before taking atenolol, according to NHS guidance - here's everything you should know.

Nottinghamshire's coroners have shared their concerns about the county's hospital trusts on nine occasions in 2025, calling ...

Viking Therapeutics, Inc. (Viking) , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the completion of ...

Continuing Phase 3 Enabling Activities, Including Discussions with U.S. Food & Drug Administration (FDA) Following Positive Phase 2b RSVHR Results for Zelicapavir, an N-Protein Inhibitor in ...

Lantheus Holdings, Inc. ("Lantheus" or the "Company") , the leading radiopharmaceutical-focused company dedicated to helping clinicians Find, Fight, and Follow disease to deliver better patient ...

People living with asthma could soon benefit from innovative digital tools on their phones or tablets to help manage their condi ...

The U.S. Food and Drug Administration has approved Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) as the first and only subcutaneously administered therapy for patients with epidermal growth ...

The U.S. Food and Drug Administration has approved Myqorzo (aficamten) for the treatment of adults with symptomatic ...